COMMUNIQUÉS West-GlobeNewswire

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
25/07/2024
Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”) , an artificial intelligence (AI)-powered medical technology [...]
HNL Lab Medicine Opens Gilbertsville Location
24/07/2024
ALLENTOWN, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- HNL Lab Medicine, a leading diagnostics laboratory, announced the opening of a new Patient Service Center. Located at 1107 Grosser Road, Gilbertsville PA, this new [...]
Amedisys Reports Second Quarter 2024 Financial Results
24/07/2024
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and [...]
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
24/07/2024
FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]
TransCode Therapeutics, Inc. Announces Closing of Public Offering
24/07/2024
BOSTON, July 24, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating cancer using RNA [...]
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
24/07/2024
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]
Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial
24/07/2024
Trial projected to be initiated shortly following receipt of drug product by trial sites NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today [...]
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
24/07/2024
CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
Un troisième produit de cannabis thérapeutique approuvé au Portugal pour Tilray Medical
24/07/2024
L’extrait de cannabis Solução Oral THC10:CBD10 conçu par Tilray sous la forme d’une solution orale est désormais approuvé pour un usage médical au Portugal CANTANHEDE, Portugal, 24 juill. 2024 (GLOBE NEWSWIRE) -- Tilray [...]
The Foundation for Sarcoidosis Research Awards $300,000 to Support Early-Career Investigators Through the Sarcoidosis Research Fellowship Grant
24/07/2024
CHICAGO, July 24, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce that Dr. Greer Waldrop, University of California, San Francisco, and Dr. Miles Hagner, University of Iowa, [...]
Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024
24/07/2024
Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Leuven, BELGIUM – 24 July, 2024 – 06.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in [...]
Spineway a Gold Sponsor at the SILACO Congress in Mexico - Organization of a special event with Latin American distributors
24/07/2024
Press release Ecully, July 24, 2024 – 6 p.m. Spineway a Gold Sponsor at the SILACO Congress in Mexico Organization of a special event with Latin American distributors The Spineway Group, a specialist in innovative [...]
Spineway Gold sponsor du congrès SILACO au Mexique - Organisation d’un évènement dédié avec les distributeurs d’Amérique Latine
24/07/2024
Communiqué de presse Ecully, le 24 juillet 2024 – 18h Spineway Gold sponsor du congrès SILACO au Mexique Organisation d’un évènement dédié avec les distributeurs d’Amérique Latine Le groupe Spineway, spécialiste des [...]
Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report
24/07/2024
PALO ALTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
ConSynance Therapeutics Announces U.S. FDA Grants Rare Pediatric Disease Designation to CSTI-500, a Potential First-in-Class Therapy for Prader-Willi Syndrome
24/07/2024
RENSSELAER, N.Y., July 24, 2024 (GLOBE NEWSWIRE) -- ConSynance Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies for rare central nervous system (CNS) disorders, today [...]
New SPECT Study Unveils Significant Brain Activity Differences in Depression
24/07/2024
Research Highlights Specific Brain Areas with Increased Activity in Depressed Patients COSTA MESA, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Researchers in a groundbreaking neuroimaging study have discovered that [...]
REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples
24/07/2024
CLEARWATER, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, is thrilled to announce that a significant distributor in the CPAP industry has [...]
CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors
24/07/2024
The sole focus of CPC’s position and lawsuit against XWELL’s entrenched Board of Directors (the “Entrenched Directors”) is to provide shareholders with an opportunity to elect a competing slate of directors to XWELL’s [...]
Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program
24/07/2024
PHOENIX, July 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ) , a leading commercial-stage biotechnology company focused on a [...]

Pages